Literature DB >> 16879025

Gliosarcoma with features of osteoblastic osteosarcoma: a review.

Valeria Barresi1, Serenella Cerasoli, Federico Morigi, Anna Maria Cremonini, Mirco Volpini, Giovanni Tuccari.   

Abstract

CONTEXT: Gliosarcoma is a rare tumor of the central nervous system characterized by a biphasic histologic pattern, consisting of a gliomatous and a sarcomatous component, respectively. In most instances the sarcomatous component is represented by a fibrosarcoma, but other stromal malignancies have also been described. Osteosarcomatous differentiation in gliosarcoma has been rarely reported.
OBJECTIVE: To review characteristic radiologic and histopathologic features of this rare neoplasm, to debate about possible differential diagnoses that should be taken into consideration, and to provide an overview of the potential histopathogenesis of gliosarcomas. DATA SOURCES: Relevant articles indexed in PubMed (National Library of Medicine) and reference medical texts.
CONCLUSIONS: Recent molecular studies suggest that sarcomatous and gliomatous components of gliosarcoma might be derived from a single precursor cell clone, progressing in 2 subclones with distinct morphologic features during tumor evolution. Nonetheless, events determining splitting of the original clone into 2 histologic populations remain to be investigated.

Entities:  

Mesh:

Year:  2006        PMID: 16879025     DOI: 10.5858/2006-130-1208-GWFOOO

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  9 in total

1.  Osteoblastic meningiomas: clinico-pathological and immunohistochemical features of an uncommon variant.

Authors:  V Barresi; M Caffo; A Ieni; C Alafaci; G Tuccari
Journal:  J Neurooncol       Date:  2011-04-22       Impact factor: 4.130

2.  Gliosarcoma with primitive neuroectodermal, osseous, cartilage and adipocyte differentiation: a case report.

Authors:  Kun Yao; Xue-Ling Qi; Xi Mei; Tao Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

3.  Primary gliosarcoma of the brain: radiologic and histopathologic features.

Authors:  Alfredo E Romero-Rojas; Julio A Diaz-Perez; Lina M Ariza-Serrano; Deirdre Amaro; Alfonso Lozano-Castillo
Journal:  Neuroradiol J       Date:  2013-12-18

4.  Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.

Authors:  David Cachia; Carlos Kamiya-Matsuoka; Jacob J Mandel; Adriana Olar; Matthew D Cykowski; Terri S Armstrong; Gregory N Fuller; Mark R Gilbert; John F De Groot
Journal:  J Neurooncol       Date:  2015-09-09       Impact factor: 4.130

Review 5.  Gliosarcoma of the cerebellar hemisphere: a case report and review of the literature.

Authors:  Sung Kyoung Moon; Eui Jong Kim; Woo Suk Choi; Chang Woo Ryu; Bong Jin Park; Juhie Lee
Journal:  Korean J Radiol       Date:  2010-08-27       Impact factor: 3.500

Review 6.  Gliosarcoma with bone infiltration and extracranial growth: case report and review of literature.

Authors:  Patrick Schuss; Christian T Ulrich; Patrick N Harter; Dominique S Tews; Volker Seifert; Kea Franz
Journal:  J Neurooncol       Date:  2010-10-19       Impact factor: 4.130

7.  DRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcoma.

Authors:  Lin Wang; Weihai Liu; Hengtao Tang; Xianbiao Xie; Changye Zou; Yongqian Wang; Zhenhua Gao; Junqiang Yin
Journal:  Cancer Med       Date:  2017-04-04       Impact factor: 4.452

8.  Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma.

Authors:  Simone Frandsen; Helle Broholm; Vibeke Andrée Larsen; Kirsten Grunnet; Søren Møller; Hans Skovgaard Poulsen; Signe Regner Michaelsen
Journal:  Front Oncol       Date:  2019-12-17       Impact factor: 6.244

9.  Brachium Pontis Gliosarcoma With Well-Differentiated Cartilaginous Tissue: A Case Report.

Authors:  Lei Wang; Yuanyang Xie; Yan Liu; Jun Tan; Zhongliang Chen; Yu Xiao; Ying Xia; Zefeng Peng
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.